|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 43/00 | (2006.01) |
| C07J 43/003 | (2013.01) | ||
| A61K 31/58 | (2006.01) | ||
| A61P 5/28 | (2006.01) | ||
| A61P 5/46 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3935068 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20717363.4 |
| Date of filing the European patent application | 2020-03-04 | |
| (97) | Date of publication of the European application | 2022-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/020915 |
| Date | 2020-03-04 |
| (87) | Number | WO 2020/180942 |
| Date | 2020-09-10 |
| (30) | Number | Date | Country code |
| 201962814568 P | 2019-03-06 | US | |
| 201962849259 P | 2019-05-17 | US |
| (72) |
SHARP, Matthew, J. , US
MOORE, William, R. , US
|
| (73) |
Propella Therapeutics, Inc. ,
480 Hillsboro Street Suite 130A, Pittsboro NC 27312,
US
|
| (54) | ABIRATERONE PRODRUGS |
| ABIRATERONE PRODRUGS |